Health BETA is pioneering Genomic Digital Therapeutics, integrating AI-driven health monitoring, genetic testing, and lifestyle tracking to revolutionize disease prevention and management. 

Our proprietary Coronary Artery Disease (CAD) Risk Prediction Model leverages polygenic risk scores (PRS) alongside lifestyle-induced factors to provide personalized health insights through an AI-powered risk prediction model. Through our Internet of Things (IoT) system, we empower cardiologists to predict and prevent secondary heart attacks by continuously monitoring evolving patient conditions. 

Health BETA is also expanding the frontier of Genes X Lifestyle Research Collaboration, working with research institutions, universities, and healthcare organizations to explore complex diseases, including cancer, metabolic disorders (such as diabetes), neurodegenerative diseases (such as dementia), hypertension, and allergies. 

Our AI-driven predictive health models integrate genetic predisposition, metabolic insights, and lifestyle data, unlocking new possibilities for precision medicine. Health BETA’s multi-modal data acquisition solutions are designed to seamlessly integrate with Hospital Information Systems (HIS), ensuring clinical-grade accuracy and regulatory compliance.